RXSight Inc. Successfully Completes Public Offering of Common Stock with Full Exercise of Underwriters’ Option to Purchase Additional Shares
RxSight, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares ALISO VIEJO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) — RxSight, Inc. (“RxSight®”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that, in connection with its previously announced public offering of common stock (the “Offering”),…